|
1
|
Fathi AR and Roelcke U: Meningioma. Curr
Neurol Neurosci Rep. 13:3372013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dubel GJ, Ahn SH and Soares GM:
Contemporary endovascular embolotherapy for meningioma. Semin
Intervent Radiol. 30:263–277. 2013. View Article : Google Scholar :
|
|
3
|
Walcott BP, Nahed BV, Brastianos PK and
Loeffler JS: Radiation Treatment for WHO Grade II and III
meningiomas. Front Oncol. 3:2272013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Saraf S, McCarthy BJ and Villano JL:
Update on meningiomas. Oncologist. 16:1604–1613. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rochman M, Malicet C and Bustin M:
HMGN5/NSBP1: A new member of the HMGN protein family that affects
chromatin structure and function. Biochim Biophys Acta. 1799:86–92.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shirakawa H, Landsman D, Postnikov YV and
Bustin M: NBP-45, a novel nucleosomal binding protein with a
tissue-specific and developmentally regulated expression. J Biol
Chem. 275:6368–6374. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rochman M, Postnikov Y, Correll S, Malicet
C, Wincovitch S, Karpova TS, McNally JG, Wu X, Bubunenko NA,
Grigoryev S, et al: The interaction of NSBP1/HMGN5 with nucleosomes
in euchromatin counteracts linker histone-mediated chromatin
compaction and modulates transcription. Mol Cell. 35:642–656. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ji SQ, Yao L, Zhang XY, Li XS and Zhou LQ:
Knockdown of the nucleosome binding protein 1 inhibits the growth
and invasion of clear cell renal cell carcinoma cells in vitro and
in vivo. J Exp Clin Cancer Res. 31:222012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wahafu W, He ZS, Zhang XY, Zhang CJ, Yao
K, Hao H, Song G, He Q, Li XS and Zhou LQ: The nucleosome binding
protein NSBP1 is highly expressed in human bladder cancer and
promotes the proliferation and invasion of bladder cancer cells.
Tumour Biol. 32:931–939. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jiang N, Zhou LQ and Zhang XY:
Downregulation of the nucleosome-binding protein 1 (NSBP1) gene can
inhibit the in vitro and in vivo proliferation of prostate cancer
cells. Asian J Androl. 12:709–717. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qu J, Yan R, Chen J, Xu T, Zhou J, Wang M,
Chen C, Yan Y and Lu Y: HMGN5: A potential oncogene in gliomas. J
Neurooncol. 104:729–736. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang Q, Wang JY, Zhang XP, Lv ZW, Fu D, Lu
YC, Hu GH, Luo C and Chen JX: RLIP76 is overexpressed in human
glioblastomas and is required for proliferation, tumorigenesis and
suppression of apoptosis. Carcinogenesis. 34:916–926. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Martinou JC and Youle RJ: Mitochondria in
apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev
Cell. 21:92–101. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Soane L and Fiskum G: Inhibition of
mitochondrial neural cell death pathways by protein transduction of
Bcl-2 family proteins. J Bioenerg Biomembr. 37:179–190. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Basu A, DuBois G and Haldar S:
Posttranslational modifications of Bcl2 family members - a
potential therapeutic target for human malignancy. Front Biosci.
11:1508–1521. 2006. View
Article : Google Scholar
|
|
16
|
Zeestraten EC, Benard A, Reimers MS,
Schouten PC, Liefers GJ, van de Velde CJ and Kuppen PJ: The
prognostic value of the apoptosis pathway in colorectal cancer: A
review of the literature on biomarkers identified by
immunohistochemistry. Biomark Cancer. 5:13–29. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Murray J and Renslo AR: Modulating caspase
activity: Beyond the active site. Curr Opin Struct Biol.
23:812–819. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
McCracken JM and Allen LA: Regulation of
human neutrophil apoptosis and lifespan in health and disease. J
Cell Death. 7:15–23. 2014.PubMed/NCBI
|
|
19
|
Vranic A: Caspase-3 and survivin
expression in primary atypical and malignant meningiomas. ISRN
Neurosci. 2013:6262902013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shiraga M, Yano S, Yamamoto A, Ogawa H,
Goto H, Miki T, Miki K, Zhang H and Sone S: Organ heterogeneity of
host-derived matrix metalloproteinase expression and its
involvement in multiple-organ metastasis by lung cancer cell lines.
Cancer Res. 62:5967–5973. 2002.PubMed/NCBI
|
|
21
|
Mandara MT, Pavone S, Mandrioli L, Bettini
G, Falzone C and Baroni M: Matrix metalloproteinase-2 and matrix
metalloproteinase-9 expression in canine and feline meningioma. Vet
Pathol. 46:836–845. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Okada M, Miyake K, Matsumoto Y, Kawai N,
Kunishio K and Nagao S: Matrix metalloproteinase-2 and matrix
metalloproteinase-9 expressions correlate with the recurrence of
intracranial meningiomas. J Neurooncol. 66:29–37. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kast RE and Halatsch ME: Matrix
metalloproteinase-2 and -9 in glioblastoma: A trio of old drugs -
captopril, disulfiram and nelfinavir - are inhibitors with
potential as adjunctive treatments in glioblastoma. Arch Med Res.
43:243–247. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chamberlain MC, Tsao-Wei DD and Groshen S:
Temozolomide for treatment-resistant recurrent meningioma.
Neurology. 62:1210–1212. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li G, Zhang H, Liu Y, Kong L, Guo Q and
Jin F: Effect of temozolomide on livin and caspase-3 in U251 glioma
stem cells. Exp Ther Med. 9:744–750. 2015.PubMed/NCBI
|
|
26
|
Akay C, Thomas C III and Gazitt Y: Arsenic
trioxide and paclitaxel induce apoptosis by different mechanisms.
Cell Cycle. 3:324–334. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang Q, Qian J, Wang J, Luo C, Chen J, Hu
G and Lu Y: Knockdown of RLIP76 expression by RNA interference
inhibits invasion, induces cell cycle arrest, and increases
chemosensitivity to the anticancer drug temozolomide in glioma
cells. J Neurooncol. 112:73–82. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schaich M, Kestel L, Pfirrmann M, Robel K,
Illmer T, Kramer M, Dill C, Ehninger G, Schackert G and Krex D: A
MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome
of temozolomide treatment in glioblastoma patients. Ann Oncol.
20:175–181. 2009. View Article : Google Scholar
|
|
29
|
Andersson U, Malmer B, Bergenheim AT,
Brännström T and Henriksson R: Heterogeneity in the expression of
markers for drug resistance in brain tumors. Clin Neuropathol.
23:21–27. 2004.PubMed/NCBI
|
